Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. - Rodriguez GI; Jones RE; Orenberg EK; Stoltz ML; Brooks DJ (Clinical cancer research : an official journal of the American Association for Cancer Research, 2002)